STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Solventum (SOLV) officer settles 10,463 RSUs, holds 15,943 shares

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Solventum Corp reported an insider equity transaction by its Chief Supply Chain Officer, who filed individually. On 12/01/2025, 10,463 shares of common stock were acquired through the settlement of fully vested restricted stock units, reflected as a Code M transaction. On the same date, 4,528 shares of common stock were disposed of in a Code F transaction at $85.56 per share, typically indicating shares withheld to cover taxes.

After these transactions, the officer beneficially owned 15,943 shares of Solventum common stock in direct ownership. All related restricted stock units were fully vested, and each RSU represented the right to receive one share of common stock upon settlement.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Harrington Paul S

(Last) (First) (Middle)
2510 CONWAY AVENUE EAST
3M CENTER, BUILDING 275-6W

(Street)
MAPLEWOOD MN 55144

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Supply Chain Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/01/2025 M 10,463 A (1) 20,471 D
Common Stock 12/01/2025 F 4,528 D $85.56 15,943 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 12/01/2025 M 10,463 (2) 12/01/2025 Common Stock 10,463 $0 0 D
Explanation of Responses:
1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
2. The RSUs are fully vested.
Remarks:
/s/ Matthew Rice, attorney-in-fact for Paul S. Harrington 12/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Solventum Corp (SOLV) report in this Form 4?

The Chief Supply Chain Officer of Solventum Corp (SOLV) reported acquiring 10,463 shares of common stock on 12/01/2025 through the settlement of fully vested restricted stock units, and disposing of 4,528 shares on the same date.

How many Solventum (SOLV) shares does the reporting officer own after the transaction?

Following the reported transactions, the officer beneficially owned 15,943 shares of Solventum common stock in direct ownership.

What do the RSUs in the Solventum (SOLV) Form 4 represent?

Each restricted stock unit (RSU) represents a contingent right to receive 1 share of Solventum common stock upon settlement. In this filing, the RSUs were stated to be fully vested.

What is the significance of transaction codes M and F in the Solventum (SOLV) Form 4?

Code M indicates the exercise or settlement of a derivative security, here the conversion of RSUs into 10,463 shares of common stock. Code F reflects the disposition of 4,528 shares at $85.56 per share, typically associated with shares used to satisfy tax withholding obligations.

Which Solventum (SOLV) executive is involved in this insider transaction and what is their role?

The reporting person is an officer of Solventum Corp, serving as the company's Chief Supply Chain Officer.

Were any derivative securities left outstanding for the Solventum (SOLV) officer after this Form 4 transaction?

No derivative securities remained; the number of restricted stock units beneficially owned after the transaction was reported as 0, following settlement into 10,463 shares of common stock.

Solventum Corporation

NYSE:SOLV

SOLV Rankings

SOLV Latest News

SOLV Latest SEC Filings

SOLV Stock Data

14.79B
147.58M
14.9%
66.72%
2.46%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
ST. PAUL